Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?

被引:45
作者
Damiano, J [1 ]
Bordier, L [1 ]
Le Berre, J [1 ]
Margery, J [1 ]
Dupuy, O [1 ]
Mayaudon, H [1 ]
Bauduceau, B [1 ]
机构
[1] Hop Instruct Armees Begin, Serv Endocrinol, F-94160 St Mande, France
关键词
diabetes mellitus; pancreatic cancer; pancreas; risk; factors; medical imaging;
D O I
10.1016/S1262-3636(07)70111-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between diabetes mellitus and cancer of the pancreas is complex and incompletely understood. Nevertheless, it is generally agreed that new-onset diabetes in a patient over 50 years old is a classical indication of pancreatic cancer. But there is no official directive in France that a scan should routinely be performed in such cases. We have studied 115 patients aged over 50 who were hospitalized for new-onset diabetes (fewer than 30 days) whose instability required insulin treatment. Routine imaging revealed abdominal disorders in 14 patients, 6 (5.2%) of whom were suffering from pancreatic adenocarcinomas. No clinical indication or laboratory test, apart from an unusually severe anorexia, suggested the discovered disorders. We therefore routinely carry out a pancreas scan, preferably by MRI, on all patients over 50 years old presenting with new-onset diabetes, even if there are not clinical or laboratory indications of cancer. This is the only way in which small pancreatic cancers can be detected, thus providing the best hopes for successful treatment. Unfortunately, too often, this approach also detects only tumors that are already well developed. However, nowadays, it is not conceivable for a clinical team to discharge a patient from hospital with such a serious disease undiagnosed.
引用
收藏
页码:203 / 207
页数:5
相关论文
共 20 条
  • [1] BALKAU B, 1993, DIABETES METAB, V19, P458
  • [2] POTENTIALLY RESECTABLE PANCREATIC ADENOCARCINOMA - SPIRAL CT ASSESSMENT WITH SURGICAL AND PATHOLOGICAL CORRELATION
    BLUEMKE, DA
    CAMERON, JL
    HRUBAN, RH
    PITT, HA
    SIEGELMAN, SS
    SOYER, P
    FISHMAN, EK
    [J]. RADIOLOGY, 1995, 197 (02) : 381 - 385
  • [3] Bright R, 1833, Med Chir Trans, V18, P1
  • [4] PANCREATIC NEOPLASMS - HOW USEFUL IS EVALUATION WITH US
    CAMPBELL, JP
    WILSON, SR
    [J]. RADIOLOGY, 1988, 167 (02) : 341 - 344
  • [5] PANCREATIC-CANCER, ALCOHOL, DIABETES-MELLITUS AND GALLBLADDER-DISEASE
    CUZICK, J
    BABIKER, AG
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (03) : 415 - 421
  • [6] EKOE JM, 1992, REV EPIDEMIOL SANTE, V40, P447
  • [7] DIABETES-MELLITUS AS A RISK FACTOR FOR PANCREATIC-CANCER - A METAANALYSIS
    EVERHART, J
    WRIGHT, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (20): : 1605 - 1609
  • [8] DIABETES AND THE RISK OF PANCREATIC-CANCER
    GULLO, L
    PEZZILLI, R
    MORSELLILABATE, AM
    PRIORI, P
    CAMPIONE, O
    CASADEI, R
    BRAMBATI, M
    LESI, C
    FRENA, A
    MALESCI, A
    ZERBI, A
    ANDRIULLI, A
    ACQUADRO, P
    DAMBROSI, A
    ALVISI, V
    MONTALTO, G
    CARROCCIO, A
    DECONCA, V
    MORNESE, A
    MANSI, C
    BATTISTINI, C
    SPERTI, C
    PASQUALI, C
    GAETA, L
    MAZZEO, M
    FELDER, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (02) : 81 - 84
  • [9] On the role of islet amyloid polypeptide in glucose intolerance and anorexia of pancreatic cancer
    Herrington, MK
    Arnelo, U
    Permert, J
    [J]. PANCREATOLOGY, 2001, 1 (03) : 267 - 274
  • [10] PANCREATIC-CANCER, BLOOD-GLUCOSE AND BEVERAGE CONSUMPTION
    HIATT, RA
    KLATSKY, AL
    ARMSTRONG, MA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (06) : 794 - 797